Meet D-Mark Biosciences, Isolation Bio and Universal Sequencing Technology, Platinum Sponsors of our Having IMPACTT: Advancing Microbiome Research Symposium on June 3-5, 2024
D-Mark Biosciences Inc, a leading Genomics Solutions Architect in Canada, leverages its extensive technical expertise to assist researchers in accelerating their discoveries. Founded in 2008, DMark excels in delivering cutting-edge solutions for molecular and protein biology. DMark’s extensive portfolio, crafted to meet the diverse needs of the scientific community, encompasses advanced solutions for sample collection, extraction, amplification, cloning, cell culture, next-generation sequencing, RNA sequencing, and more. As a team of dedicated technical experts, DMark ensures researchers access the latest technological advancements to drive their research forward.
Through the IMPACTT symposium, DMark is dedicated to addressing pain points in microbial research and are here to strongly support microbial researchers in their pursuit of innovative discoveries.
Learn more about D-Mark Biosciences at our website and follow us on LinkedIn.
At IMPACTT, D-Mark Biosciences proudly introduces microbial researchers to the powerful technologies offered by Isolation Bio and Universal Sequencing Technologies. These powerful tools are part of our steadfast commitment to enhancing research efficiency, conserving resources, and generating more comprehensive data. By integrating these advanced solutions into our streamlined workflow solutions, we aim to significantly improve the quality and speed of microbiome scientific discoveries, empowering researchers to achieve more with less time and effort.
Welcome to a new era of scientific discovery with D-Mark Biosciences, where innovation meets excellence.
Isolation Bio is pushing the boundaries of microbiome science to liberate researchers from the confines of outdated microbial techniques. Our company is driven to propel researchers into a new era of ground-breaking microbial research.
Our Prospector® platform enables true high-throughput microbial isolation and cultivation to scale up discovery while also revealing rare microbes that traditional microbiology methods might miss, and our microbial isolation and cultivation service makes that power accessible at scale by providing custom solutions for fast and cost-effective discovery.
Learn more about Isolation Bio at our website and follow us on Twitter/X and LinkedIn.
Universal Sequencing Technology (UST) is an innovative US biotechnology company founded in 2015 with headquarters in San Diego, California. UST is dedicated to the development and commercialization of disruptive next-generation sequencing (NGS) solutions and products.
Since inception, UST has developed multiple cutting-edge NGS technologies, which includes TELL-Seq™ linked read library preparation technology, a now commercially available proven technology that enables short-read NGS platforms, such as Illumina sequencers, to produce super long read results (20kb to 200kb or longer). An Illumina sequencing ready library can be prepared in 3 hours in a PCR tube, simple, fast and cost effective. TELL-Seq library prep does not require any special lab equipment and is automation friendly. TELL-Seq linked read library can help short read NGS users to do many previously unachievable long read applications, such as de novo sequencing, microbial genome assembly, metagenomics, human genome phasing (whole genome and target), structural variation detection, gene editing QC, PGT (preimplantation genetic tests) and newborn screening, etc.
TELL-Seq results are proven to be accurate and require very little DNA input (0.1 – 0.5 ng or less for bacteria and targeted gene panels, 3 – 5 ng for human genome and complex metagenomic samples). Recent development at UST on TELL-Seq allows pooling of up to 384 microbial isolate or microbiome samples per lane/run to take advantage of the low-cost sequencing provided by high throughput sequencing platforms such as Illumina’s NextSeq2000, NovaSeq6000, NovaSeqX and Element’s Aviti. With a co-marketing and co-development relationship signed with Illumina, the TELL-Seq technology is a valuable tool for genomics research and proven to be the best tool for microbiome analysis.
To learn more about Universal Sequencing Technology, visit our website at www.universalsequencing.com and follow us on Twitter/X.
